PharmaLundensis AB (XSAT:PHAL) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:PHAL PharmaLundensis AB XSAT:PHAL
25 GF Score
Price kr0.32
! 1 Warning Sign
View Full Analysis

What is PharmaLundensis AB FFO?

FFO (Funds from operations) only applies to REITs.

XSAT:PHAL
25GF Score
PharmaLundensis AB XSAT:PHAL
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaLundensis AB Business Description

Address PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63
PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.
25GF Score

Get the complete analysis for XSAT:PHAL

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.32
Price